Lenvatinib induces ferroptosis-related changes in osteosarcoma cells involving the p-STAT3/p53/xCT axis - Top-Institutions - MDSpire

Lenvatinib induces ferroptosis-related changes in osteosarcoma cells involving the p-STAT3/p53/xCT axis

  • By

  • Chunwang Yang

  • Yulong Ma

  • Wenxiang Shen

  • Xiaozhong Ma

  • Xiang Liu

  • Shaowen Du

  • Kaishan Ye

  • May 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Gustave Roussy Cancer Centre
    Gustave Roussy Cancer Centre

    Villejuif, Île-de-France

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    Harvard Medical School
    Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #4

    University of Paris Sud
    University of Paris Sud

    Orsay, Île-de-France

    Key Differentiators

    • Oncology

  • #5

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

Original Source(s)

Lenvatinib induces ferroptosis-related changes in osteosarcoma cells involving the p-STAT3/p53/xCT axis

  • by Chunwang Yang, Yulong Ma, Wenxiang Shen, Xiaozhong Ma, Xiang Liu, Shaowen Du, Kaishan Ye

  • May 29, 2026

Related Content

Identification of MTMR2 as an AML-associated candidate biomarker derived from lipid metabolism–related transcriptomic analysis

High-grade astrocytoma with piloid features: a case report of comprehensive management

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications